Tackling NUP98 Rearranged AML in Pediatric Oncology - Ep 3.5
Description
Host Dr Charles de Bock speaks with Prof Michel Zwaan and Prof Olaf Heidenreich, co-authors from the 2025 HemaSphere Award - Top Cited: Biology paper, "The MLL-Menin Interaction is a Therapeutic Vulnerability in NUP98-rearranged AML." The conversation delves into the complexities of #AML, particularly focusing on NUP98 rearranged AML and the therapeutic potential of Menin inhibitors. The discussion highlights the challenges in treating this aggressive form of leukemia, the mechanisms of menin inhibitors, and the importance of combining therapies to improve patient outcomes.
Season 3, Episode 5: Tackling NUP98 Rearranged AML in Pediatric Oncology, is on our website and all major podcast platforms. Listen and enjoy casual, insightful discussions about #hematology research.
United States
